In their publication in Nature Chemical Biology PROXIDRUGS researchers and collaborating universities have discovered a way to prevent...

Since the beginning of this year, 22 partners from academic and industrial research are working collaboratively together in the 2nd...

The 4th Frankfurt Conference on Quality Control in Life Processes welcomed more than 300 speakers and attendees from all over the world....

A new computational drug design challenge is being launched from our PROXIDRUGS partner Merck KGaA: the Proximity-Inducing Drugs...

Targeted protein degradation (TPD) is an emerging therapeutic strategy that hijacks the cellular recycling machinery to degrade and...

On November 18th and 19th present and new industry and academic partners came together for the annual PROXIDRUGS retreat to discuss...

With Ivan Đikić and Gerhard Hummer two PROXIDRUGS Project Leaders are recognized as Highly Cited Researchers in their fields on...

In a study published in today’s issue of Science, a team around PROXIDRUGS speaker Ivan Đikić reveals how cells deploy ubiquitination and...

The PROXIDRUGS Innovation Management team, together with PROXIDRUGS partners Paul Gehrtz , Principal Scientist MedChem at Merck Gruppe ...

PROXIDRUGS speaker Ivan Đikić has been awarded a prestigious LOEWE-Spitzenprofessur at Goethe University Frankfurt. The Hessian LOEWE...